Segment disclosures

Company overview

아스테라시스

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3011222466667 KRW20260814Open filing evidence
2026-01-01 – 2026-06-3018692997802 KRW20260814Open filing evidence
2026-01-01 – 2026-03-317470531135 KRW20260515Open filing evidence
2025-01-01 – 2025-12-3137943714291 KRW20260316Open filing evidence
2025-07-01 – 2025-09-308751547472 KRW20251113Open filing evidence
2025-01-01 – 2025-09-3025778058100 KRW20251113Open filing evidence
2025-04-01 – 2025-06-3010336793548 KRW20260814Open filing evidence
2025-01-01 – 2025-06-3017026510628 KRW20260814Open filing evidence
2025-01-01 – 2025-03-316689717080 KRW20260515Open filing evidence
2024-01-01 – 2024-12-3128833182740 KRW20260316Open filing evidence
2024-07-01 – 2024-09-306775612314 KRW20251113Open filing evidence
2024-01-01 – 2024-09-3018138956865 KRW20251113Open filing evidence
2024-04-01 – 2024-06-307844325918 KRW20250813Open filing evidence
2024-01-01 – 2024-06-3011363344551 KRW20250813Open filing evidence
2024-01-01 – 2024-03-313519018633 KRW20250514Open filing evidence
2023-01-01 – 2023-12-3117497984287 KRW20260316Open filing evidence
2022-01-01 – 2022-12-3115617727519 KRW20250313Open filing evidence